RYAN CLEMENTS, Managing Director, KPMG

Background

•   Ryan has over 15 years of advisory experience focused on the life sciences and healthcare sectors serving a varied client base from Fortune 20 to early stage and pre-commercial market entrants as well as mid-market and leading global financial services companies. Lindsey pulls from her strong analytical background and experience working with a variety of healthcare organizations in diverse markets to deliver data-driven advisory services.

•   Prior to KPMG, Ryan was a Managing Director at Avalere Health, a boutique life sciences and healthcare focused Advisory firm based in Washington DC, well known for government affairs, corporate affairs and both state and federal policy strategy work. Ryan led many of the firms operations including a variety of initiatives to acquire and expertly deploy various data assets into the firm’s advisory offerings. Ryan led many of the firm’s premiere biopharma and life sciences client relationships, with oversight for the work his teams executed related to health economics and advanced analytics, market access and government affairs.

•   Ryan was a Director and founder of Red Oak Sourcing, a joint venture between CVS Health and Cardinal Health.  Ryan and his team at Red Oak were responsible for managing the generic drug portfolio on behalf of both parent companies, including negotiating dead net cost with generic drug manufacturers, understanding competitive dynamics on generic launches and break opens, developing inventory management strategies, mitigating supply risk and optimizing supply chain strategy, and understanding regulatory, FDA and government affairs dynamics in play for the generics industry

•   Before his time at Red Oak, Ryan worked for PwC focused on life sciences and medical device clients

Example Experience

• Launched the largest generic pharmaceutical portfolio manager in the history of the United States
• Implemented generic drug DSCSA program for largest retail pharmacy in US and a big three drug wholesaler
• Developed inventory management and supply chain strategy for 10,000 item generic drug formulary
• Strategic design of API data base to drive greater diversity of product sourcing and minimize supply disruption
• Generic sourcing operational integration of $12.9B long term care pharmacy into largest retail pharmacy in US
• Generic sourcing operational integration of $2B pharmacy carve out into largest retail pharmacy in US
• Generic sourcing operational integration of $1.1B drug repackaging and private label manufacturer into a big three wholesaler
• Strategic PMO for top 3 pharma manufacturer rare disease product launch focused on pricing and government affairs strategy
• Developed patient identification and activation program to drive vaccines adherence for a top 4 global vaccines manufacturer
• Executive testimony strategy and preparation for big pharma CEO testifying before Senate Finance Committee
• Commercial strategy transformation and landscape analysis for mid-market biotech